Point72 Hong Kong’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Point72 Hong Kong’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,652	Closed	-$98K	–	2588
2021 Q3	$98K	Buy	+1,652	New	+$97.6K	﹤0.01%	1350
2021 Q2	–	Sell	-510	Closed	-$35K	–	2504
2021 Q1	$35K	Sell	510 -288	-36%	-$22.2K	﹤0.01%	1356
2020 Q4	$61K	Buy	+798	New	+$59.8K	﹤0.01%	1174
2020 Q2	–	Sell	-117	Closed	-$5K	–	1514
2020 Q1	$5K	Sell	117 -200	-63%	-$9.17K	﹤0.01%	789
2019 Q4	$14K	Sell	317 -1,058	-77%	-$50K	﹤0.01%	947
2019 Q3	$63K	Buy	+1,375	New	+$77.3K	0.02%	535
2018 Q4	–	Sell	-3,257	Closed	-$150K	–	1307
2018 Q3	$150K	Buy	+3,257	New	+$132K	0.05%	262

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Hong Kong's ARNA Position: Q4 2021 in Review

Point72 Hong Kong sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 1,652 shares — an estimated $98K sold.

Point72 Hong Kong first reported a position in ARNA in Q3 2018 and held it in 7 quarters. The position peaked at $150K in Q3 2018. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Point72 Hong Kong reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 1,652 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $98K.
Point72 Hong Kong first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 7 quarters.
Point72 Hong Kong's Arena Pharmaceuticals Inc position peaked at $150K in Q3 2018.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.